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cense.Abstract Purpose: The purpose of this study is to evaluate the ability of multidetector CT
(MDCT) in predicting resectability of pancreatic tumors.
Patients and methods: Thirty-nine patients were included in this study, there were 29 males and 10
females, and their age range was 44–73 years with a mean age of 58.3 years. All the patients were
subjected to contrast enhanced biphasic examinations on 64-slice CT machine.
Results: Twenty-one patients (53.8%) were considered inoperable with unresected tumor, the
remaining 18 patients (46.2%) were considered suitable for tumor resection according to MDCT
criteria. 15 out of the 18 patients (83.3) had a successful tumor resection while the remaining 3
(16.7%) showed unresectable tumor during operation. On the basis of pathology results 12 patients
out of the 18 (66.7%) had successful surgery with negative tumor margin, and a positive predictive
value of 66.7% and accuracy of 66.7%.
Conclusions: There is better prediction of resectability of pancreatic tumors with the development of
MDCT technology. As compared to Helical computed tomography (HCT) studies, there is a rise incom (E.M. Khattab).
of Radiology and Nuclear
sevier B.V.
tian Society of Radiology and
lsevier
12 E.M. Khattab et al.the rate of successful surgical resection. The positive predictive value of multidetector computed
tomography for resectable pancreatic tumors is decreased when pathologic results are used as a ref-
erence standard.
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Pancreatic cancer is one of the most aggressive human malig-
nancies. It represents the fourth most frequent cause of cancer-
related death and the second most frequent cause, after colo-
rectal cancer, when considering digestive tract cancers alone
(1). Because of its silent course, late clinical symptoms, and
rapid growth patterns, it has been named the ‘‘silent killer’’
(2,3). About 15–20% of the patients have resectable disease
at the time of presentation (4). Surgical resection offers the
only chance for cure with reported 5-year survival rates of 8–
21% (3). Tumors are considered unresectable when metastatic
disease or local vascular invasion is present. The vessels most
often involved are the celiac trunk, the hepatic artery, the supe-
rior mesenteric artery, as well as, the superior mesenteric vein
and the portal vein (4). Because of the recent improvements in
radiologic techniques, a wide range of imaging tools is now
available, such as helical CT, MR imaging, endoscopic sonog-
raphy, endoscopic retrograde cholangiopancreatography, and
angiography (5). Contrast enhanced, helical computed tomog-
raphy (HCT) and more recently multi-detector computed
tomography (MDCT) have been widely accepted as the imag-
ing technique of choice for the staging of pancreatic adenocar-
cinoma (4). The main role of preoperative staging procedures
is to distinguish between potentially resectable and non-resect-
able patients so that unnecessary surgical procedures may be
avoided; survival beneﬁts can be achieved only in patients in
whom the tumor can be completely resected (5). A signiﬁcant
number of patients are still incorrectly diagnosed as having
resectable tumor on CT only to be unresectable at surgery.
The proportion of patients undergoing unnecessary laparot-
omy may vary between 21% and 44% (4).
The purpose of this study is to evaluate accuracy of 64-slice
multidetector CT (MDCT) in preoperative assessment of
resectability of pancreatic cancer using the surgical outcome
and pathologic results as a reference standard.
2. Patients and methods
Between December 2009 and August 2011, 39 patients with
clinical and sonographic ﬁndings that raised suspicions of pan-
creatic cancer were included in our study. They were 29 males
and 10 females. Their age ranged from 44 to 73 years with a
mean age of 58.3 years. All the patients underwent MDCT
examination with 64-slice CT scan after obtaining a prior
consent.
2.1. CT examination technique
All examinations were performed with the same 64-slice CT
scan (Light speed volume VCT, GE medical system, Milwau-
kee, WI, USA). Prior to examinations patients drank
1000 mL of mixed water and contrast to demarcate the duode-
num and delineate the pancreatic head region. All patientsreceived an intra-venous injection of 100 ml of Omnipaque
350 (Amersham, GE Healthcare, Canada) at a rate of 4 ml/s.
The protocol of 64-slice MDCT was biphasic, performed with
a detector width of 0.625 mm, a section width of 1.5 mm and
an interval reconstruction of 0.5 mm. The scan done by bolus
tracking at (110 H.U.) threshold at the aorta at corresponding
level of superior mesenteric artery. The scan delay after
contrast injection 20 s for pancreatic arterial phase and 50 s
for delayed venous phase. All images were interpreted on a pic-
ture archiving and communication system (PACS) worksta-
tion. Curved and multiplanar reformations were obtained at
a dedicated post-processing workstation (Advantage Win-
dows Volume share 4.5, GE Medical System, Milwaukee,
WI, USA). Multidetector CT (MDCT) scans were analyzed
prior to surgery to determine resectability.
2.2. Image analysis
Axial images and multiplanar reconstructions with coronal
and sagittal reformations were obtained for all patients. Our
patients were classiﬁed into two groups: group A included pa-
tients who had lesions which are resectable or probably resect-
able according to CT criteria, and group B included patients
who had lesions deﬁnitely unresectable according to CT crite-
ria. Criteria of unresectability included: 1- Tumors which were
larger than 2 cm in size (tumors less than 2 cm may be associ-
ated with favorable outcome (6)), 2- Presence of local metasta-
sis (such as enlarged lymph nodes outside peripancreatic
draining chains) or direct invasion of the surrounding organs
with exclusion of the duodenum, or more, 3- Distant metasta-
ses (liver or pulmonary metastasis), 4- Inﬁltration of the walls
of major vessels including (celiac trunk, hepatic artery, splenic
artery, superior mesenteric artery and portal vein or the
superior mesenteric vein). Arterial Vascular involvement was
estimated using the criteria by Lu et al. (7) grade 0, no conti-
guity of tumor to vessel; grade 1, tumor contiguous less than
one quarter of circumference; grade 2, between one quarter
and one half; grade 3, between one half and three quarters;
grade 4, greater than three quarters. Grade 0–2 was considered
operable, whereas grades 3 and 4 were considered radiologi-
cally inoperable. Venous invasion was deﬁned as tumor-to-ves-
sel circumferential contiguity of 50% or more. Tumor-to-vein
circumferential contiguity of less than 50% was not considered
venous invasion (5).
So our patients were assessed for tumor resectability
according to (1) tumor size, (2) local spread, and/or (3) distant
spread and (4) vascular involvement.
All the examinations were reviewed by at least two radiol-
ogists followed by discussing the results with the surgeon. In
cases with discrepancy between the dual MDCT reports an
open discussion was done until reach to ﬁnal diagnosis.
According to our data collection and interpretation,
patients were divided into two groups on the basis of preoper-
ative MDCT criteria: Group A included patients who had
Table 1 Classiﬁcations of patients according to preoperative
MDCT criteria.
Resectable
Group A
Unresectable
Group B
Total no of
patients
MDCT ﬁndings 18 21 39
Table 2 Resectability of MDCT correlated with surgical
outcome.
Resectable tumors
by surgery
Unresectable Tumors
by surgery
Total No. of
patients
MDCT resectable
N= 18 15 3 18
Table 3 Resectability of MDCT correlated with pathological
results.
Free margin Positive tumor
margin
Total No. of
patients
MDCT resectable
N= 15 12 3 15
Table 4 Accuracy and positive predictive values of resect-
ability of MDCT in correlation with surgical outcome and
pathological results.
Surgical outcome
No = 18
Pathological results
No = 15
MDCT PPV of resectability 83.3% 66.7%
MDCT accuracy 83.3% 66.7%
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criteria (18 patients) and those were included in the data anal-
ysis, while group B included patients with deﬁnitely unresec-
table disease (21 patients) were excluded from our statisticalFig. 1 Axial MDCT of 54 years old man (venous phase) shows small
of less than 50% with the superior mesenteric vein (SMV) reported asdata analysis. On the basis of surgical outcomes and patholog-
ical results the MDCT ﬁndings were retrospectively reviewed
to assess positive predictive value and accuracy in detecting tu-
mor resectability.
2.3. Statistical analysis
Accuracy and positive predictive values for resectability of
MDCT were calculated by using surgical results and patholog-
ical ﬁndings (regarding the presence or absence of tumor inﬁl-
tration at the surgical margins) as a reference standard.
3. Results
Thirty-nine patients were included in our study; all the patients
underwent 64-slice MDCT examination. Out of the 39 patients
21 (53.8) were diagnosed as unresectable tumors, 16 out of 21
patients (76.2%) showed associated liver metastasis, one pa-
tient out of 21 (4.8%) showed both liver and lung metastasis
with ascitis, 3 patients (14.3%) showed vascular involvement
of superior mesenteric artery (grade 3 and 4 according to Lu
et al (7)), and last patient (4.8%) showed tumor encasement
of superior mesenteric vein with possible venous thrombosis.
18 patients out of 39 (46.2%) were diagnosed according to
our criteria as resectable pancreatic masses. All the 18 patients
underwent surgical operations within 7–25 days (with mean
14.5 days) post MDCT examination, 15 out of the 18
(83.3%) had successful tumor resection with positive predictive
value for resectability 83.3% and accuracy of 83.3%, while 3
(16.7%) patients had unresectable pancreatic masses (one pa-
tient showed invasion of the superior mesenteric vein with inﬁl-
tration of the root of mesentery, one patient showed small liver
metastasis with unexpected metastatic lymph node the last one
showed superior mesenteric artery involvement). All the three
patients underwent palliative procedures. On the basis of path-
ologic results (considering the positive surgical margin), 3 out
of the 15 (20%) patients, who underwent a Whipple procedure
and were believed to be resectable on the basis of MDCT, were
found to have positive surgical margins. So our positive
predictive value of MDCT for overall resectability fell topancreatic head non enhanced hypodense focal mass in contiguity
resectable tumor mass (true positive).
Fig. 2 Axial MDCT with sagittal reformation (arterial phase) in 48 years old man shows uniform enhanced pancreatic body mass in
contiguity with the splenic artery less than 50% reported as resectable case (true positive).
Fig. 3 Axial MDCT (arterial phase) in 64 years old male with
pancreatic body mass abutting both SMA and SMV reported as
probably resectable mass, while during laparotomy unexpected
SMV invasion was detected with failed surgical resection (false
positive).
Fig. 4 Axial MDCT (arterial phase) in 44 years old male patient with
branches (Lu grade 4), picture of deﬁnite unresectability.
14 E.M. Khattab et al.66.7% (12 out of the 18) and overall accuracy of 66.7%
(Tables 1–4 and Figs. 1–7).
4. Discussion
The indications for radical pancreaticoduodenectomy for pan-
creatic cancer have expanded over recent years as a result of a
dramatic decline in surgical mortality rates (8). However,
according to the ﬁndings of a recent surgical series, less than
20% of pancreatic cancers are amenable to surgical resection
(9). Moreover, prognosis is not improved for patients whose
tumors are resected with positive margins or vascular invasion
(10,11). The reasons for unresectability include unsuspected li-
ver metastasis, vascular invasion, lymph node metastasis, and
peritoneal carcinomatosis (5).
The accurate determination of resectability in patients with
pancreatic cancer is the most important contribution of pre-
operative staging; the goal being to reduce needless surgery
to a minimum (4). On the other hand, for patients with unre-
sectable lesions, laparotomy for palliative procedures haslarge pancreatic body mass encasing the celiac trunk and its main
Fig. 5 Axial MDCT with coronal reformation (arterial phase) in a 68 years old male with cystic mass of the uncinate process away from
the vascular structures, reported as resectable mass despite of associated ascitis (true positive case).
Fig. 6 Axial MDCT with sagittal and coronal reformation (venous phase) in a 66 years old man shows a pancreatic head mass encasing
the SMV with possible thrombosis, which are a CT sign of deﬁnite unresectability.
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and percutaneous methods of biliary and duodenal decompres-
sion (4). The improvement in CT technology has been paral-
leled by an improvement in the ability of CT to predict
resectability. In our study based on surgical outcome, the pro-
portion of patients submitted to surgery whose pancreatic tu-
mors were successfully resected was 83.3% (15 out of 18). In
the study reported by Vargas et al., the resection rate was
80% (12). In previously published series using helical CT
(HCT), the resection rate varied between 28% and 73.5%
(13–15). In the study published by Phoa et al., using a dual
detector HCT, the resection rate was 57% (16). Vargas et al.
reported a predictive value for the ability of MDCT to detectresectability of 87% (12). Our results show a predictive value
of 83.3% for resectability when compared to surgical outcome.
Comparing CT results to pathologic ﬁndings modiﬁed our re-
sults. Our prediction of resectability reduced to 66.7% with
three patients showed positive tumor margin (negative tumor
margins are requirement for successful resection). Similarly,
Phoa et al. (16) also showed a decrease in the predictive value
for resectability (from 72% to 50%), when pathologic, rather
than surgical, correlation was considered.
In our study the overall patients with failed surgery and
were believed to had resectable lesions on the basis of preoper-
ative MDCT were 6 out of 18 (33.3%) with overall accuracy of
66.7%. The limitations of our study including failure to
Fig. 7 Axial MDCT with coronal and sagittal reformations in 55 years old male patient shows a pancreatic head mass abutting and
displacing the SMA and SMV. This lesion diagnosed as unresectable pancreatic mass because of two small hepatic metastasis.
16 E.M. Khattab et al.evaluate the predictive value for unresectability all the 21 pa-
tients (53.8%) with unresectable tumor showed aggressive dis-
ease with local or distant metastasis as well as vascular
invasions, no patients submitted to surgery, with no way to
correlate the CT ﬁndings with accurate staging. In the current
study, 12 patients had their tumors successfully resected, repre-
senting 30.7% of all patients (39) initially evaluated. This per-
centage is higher than the literature reports, as only 15–20% of
patients have resectable disease at the time of presentation (4).5. Conclusion
With the advance of MDCT technology there is improvement
in prediction of resectability of pancreatic tumors when com-
pared to HCT studies, there is a rise in the rate of successful
surgical resection with the decrease in the rate of palliative sur-
gery. Despite technology advances, a group of patients remains
with early but locally invasive pancreatic tumors, where ana-
tomical imaging is unable to predict inoperability. Another
limitation is difﬁculty in measuring the predictive value of
unresectability since no patients in our study with unresectable
disease undergo laparotomy.
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